One trial showed that the creatine group lost 7.2% body fat versus 5.1% in the placebo group over 12 weeks, despite similar total weight loss
Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: a double-blind cross-over study
Approximately 30% of patients achieve a partial remission with doxorubicin.[4] The combination of doxorubicin plus cisplatin appears to be more active than doxorubicin alone and has produced more complete responses.[5] The combination of chemotherapy plus radiation therapy after complete resection may provide prolonged survival in some patients, but this treatment combination has not been compared with any one modality alone.[6,7] An estimated 25% of patients with anaplastic thyroid cancers have an activating BRAF V600E variant.[8] Evidence (dabrafenib and trametinib): A phase II trial of BRAF and MEK inhibitors, dabrafenib and trametinib, included 16 patients with anaplastic thyroid cancer and a BRAF V600E variant.[9][Level of evidence C2] The confirmed overall response rate was 69%
Vitamin C l cht chng oxy ha c kh nng bo v t bo bng cch chng li cc tc ng ca cc gc t do, cc phn t ny gp phn gy ra nguy c bnh tim, ung th v cc bnh tt khc
The results showed that LY3298176 had a dose-dependent effect on reducing HbA1c levels, and the reduction was greater than that achieved with dulaglutide or the placebo
Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, et al
